Wells: Pharmacotherapy Handbook 8th Edition

Pharmacotherapy Handbook 8th Edition provides practitioners and students with the critical information necessary to support drug therapy decision making for more than 140 diseases and disorders. Featuring a convenient alphabetized presentation, this handy guide utilizes tables, texts, figures, and treatment algorithms to make the information readily accessible and easily understood.

The consistent chapter organization includes:

• Disease state definition
• Review of relevant pathophysiology
• Clinical presentation
• Diagnosis 
• Desired outcome
• Treatment
• Monitoring

The Treatment section usually includes nonpharmacologic therapy, drug selection guidelines, dosing recommendations, adverse effects, pharmacokinetic considerations, and important drug interactions.

Contents 

SECTION 1: BONE AND JOINT DISORDERS, Edited by Terry L. Schwinghammer

• 1. Gout and Hyperuricemia
• 2. Osteoarthritis
• 3. Osteoporosis
• 4. Rheumatoid Arthritis

SECTION 2: CARDIOVASCULAR DISORDERS, Edited by Terry L. Schwinghammer

• 5. Acute Coronary Syndromes
• 6. Arrhythmias
• 7. Cardiac Arrest
• 8. Dyslipdemia
• 9. Heart Failure
• 10. Hypertension
• 11. Ischemic Heart Disease
• 12. Shock
• 13. Stroke
• 14. Venous Thromboembolism

SECTION 3: DERMATOLOGIC DISORDERS, Edited by Terry L. Schwinghammer

• 15. Acne Vulgaris
• 16. Dermatologic Drug Reactions and Common Skin Problems
• 17. Psoriasis

SECTION 4: ENDOCRINOLOGIC DISORDERS, Edited by Terry L. Schwinghammer

• 18. Adrenal Gland Disorders
• 19. Diabetes Mellitus
• 20. Thyroid Disorders

SECTION 5: GASTROINTESTINAL DISORDERS, Edited by Joseph T. DiPiro and Terry L. Schwinghammer

• 21. Cirrhosis and Portal Hypertension
• 22. Constipation
• 23. Diarrhea
• 24. Gastroesophageal Reflux Disease
• 25. Hepatitis, Viral
• 26. Inflammatory Bowel Disease
• 27. Nausea and Vomiting
• 28. Pancreatitis
• 29. Peptic Ulcer Disease

SECTION 6: GYNECOLOGIC AND OBSTETRIC DISORDERS, Edited by Barbara G. Wells

• 30. Contraception
• 31. Menopause & Perimenopausal & Postmenopausal Hormone Therapy
• 32. Pregnancy and Lactation: Therapeutic Considerations

SECTION 7: HEMATOLOGIC DISORDERS, Edited by Cecily V. DiPiro

• 33. Anemias
• 34. Sickle Cell Disease

SECTION 8: INFECTIOUS DISEASES, Edited by Joseph T. DiPiro

• 35. Antimicrobial Regimen Selection
• 36. Central Nervous System Infections
• 37. Endocarditis
• 38. Fungal Infections, Invasive
• 39. Gastrointestinal Infections
• 40. Human Immunodeficiency Virus Infection
• 41. Influenza
• 42. Intraabdominal Infections
• 43. Respiratory Tract Infections, Lower
• 44. Respiratory Tract Infections, Upper
• 45. Sepsis and Septic Shock
• 46. Sexually Transmitted Diseases
• 47. Skin and Soft-Tissue Infections
• 48. Surgical Prophylaxis
• 49. Tuberculosis
• 50. Urinary Tract Infections and Prostatitis
• 51. Vaccines, Toxoids, and Other Immunobiologics

SECTION 9: NEUROLOGIC DISORDERS, Edited by Barbara G. Wells

• 52. Alzheimer's Disease
• 53. Epilepsy
• 54. Headache: Migraine and Tension-Type
• 55. Pain Management
• 56. Parkinson's Disease
• 57. Status Epilepticus

SECTION 10: NUTRITIONAL DISORDERS, Edited by Cecily V. DiPiro

• 58. Assessment of Nutrition Status and Nutrition Requirements
• 59. Enteral Nutrition
• 60. Obesity
• 61. Parenteral Nutrition

SECTION 11: ONCOLOGIC DISORDERS, Edited by Cecily V. DiPiro

• 62. Breast Cancer
• 63. Colorectal Cancer
• 64. Lung Cancer
• 65. Lymphomas
• 66. Prostate Cancer
• 67. Renal Cell Carcinoma

SECTION 12: OPHTHALMIC DISORDERS, Edited by Cecily V. DiPiro

• 68. Glaucoma

SECTION 13: PSYCHIATRIC DISORDERS, Edited by Barbara G. Wells

• 69. Anxiety Disorders
• 70. Bipolar Disorder
• 71. Major Depressive Disorder
• 72. Schizophrenia
• 73. Sleep Disorders
• 74. Substance-Related Disorders

SECTION 14: RENAL DISORDERS, Edited by Cecily V. DiPiro

• 75. Acid-Base Disorders
• 76. Acute Kidney Injury
• 77. Chronic Kidney Disease
• 78. Drug Therapy Individualization for Patients with Chronic Kidney Disease
• 79. Electrolyte Homeostasis

SECTION 15: RESPIRATORY DISORDERS, Edited by Terry L. Schwinghammer

• 80. Allergic Rhinitis
• 81. Asthma
• 82. Chronic Obstructive Pulmonary Disease

SECTION 16: UROLOGIC DISORDERS, Edited by Cecily V. DiPiro

• 83. Benign Prostatic Hyperplasia
• 84. Erectile Dysfunction
• 85. Urinary Incontinence

APPENDICES, Edited by Barbara G. Wells

• Appendix 1: Allergic and Pseudoallergic Drug Reactions
• Appendix 2: Geriatrics
• Appendix 3: Drug-Induced Hematologic Disorders
• Appendix 4: Drug-Induced Liver Disease
• Appendix 5: Drug-Induced Pulmonary Disease
• Appendix 6: Drug-Induced Kidney Disease

Index

About the Author

• Barbara G. Wells, PharmD, FASHP, FCCP, BCPP, Dean and Professor, Executive Director, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, Oxford, Mississippi.
• Joseph T. DiPiro, PharmD, FCCP, Professor and Executive Dean, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, and University of South Carolina, Columbia.
• Terry L. Schwinghamamer, PharmD, FCCP, FASHP, FAPhA, BCPS, Professor and Chair, Department of Clinical Pharmacy, School of Pharmacy, West Virginia University, Morgantown, West Virginia.
• Cecily V. DiPiro, PharmD, Consultant Pharmacist, Mount Pleasant, South Carolina.

Product Details

• Paperback: 1176 pages
• Publisher: McGraw-Hill Medical; 8 edition (October 10, 2011)
• Language: English
• ISBN-10: 0071748342
• ISBN-13: 978-0071748346
• Product Dimensions: 8.2 x 4.7 x 1.9 inches

List Price: $55.00